Israel considers altering MSM blood donation ban

An advisory panel of the Israeli Health Ministry next month is set to discuss a policy that will allow men who have sex with men to donate blood. The policy, if implemented, would allow MSM to donate 10 years after last sexual...[more]

$10M grant will support research into von Willebrand Disease

The National Heart, Lung, and Blood Institute awarded researchers from the Medical College of Wisconsin a five-year grant worth $10 million to continue their study of molecular and genetic factors that cause the hereditary...[more]

Preventive hepatitis C vaccine goes to midstage trial

Okairos initiated a midstage trial of a gene-based preventive vaccine against hepatitis C using NIH funding. While most vaccines prompt an antibody response, Okairos' vaccine is designed to stimulate T cells, which help the body...[more]

Hepatitis C drug performs well in clinical trial

Researchers conducting a Phase II trial could not detect the hepatitis C virus in the blood of 74% of patients with HIV and hepatitis C 12 weeks after the end of treatment with Incivek, in combination with pegylated interferon...[more]

Firms strike licensing deal for hepatitis C vaccines

Akshaya Bio granted Nuron Biotech an exclusive option to license its prophylactic and therapeutic products for hepatitis C. The first of the vaccine candidates is expected to advance to clinical trials next year. American City...[more]

REGENX and Asklepios Enter into Agreement for Treatments for Hemophilia A using NAV(TM) rAAV8

regenxbio.com/resources/uploads/general_files/Regenx%20Chatham%20Press%20Release.pdf[more]

Ultrasound Dx of HCV Effective in Liver Transplant

A non-invasive diagnostic method can accurately pick up fibrosis and cirrhosis in patients with recurrent hepatitis C after a liver transplant, researchers reported. full story

Source: medpagetoday[more]